Entyvio
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Entyvio in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Entyvio.
24
Global Revenue Ranking
20
2030 Global forecast Ranking
Recent articles on PMLiVE featuring Entyvio
Approximately 538,000 new cases of colorectal cancer were diagnosed in Europe in 2022
Inflammatory bowel disease affects around ten million people worldwide
Takeda’s Asit Parikh talks about a game changer for IBD patients and the company’s long-term strategy for gene and cell therapy
Lilly’s migraine med Emgality receives negative opinion for label extension
Intravenous Entyvio is already available in 60 countries
Was seeking approval in moderate-to-severe ulcerative colitis
The 19th annual PMEA programme saw its highest number of entries yet
Hopes to aid growth
Entyvio is important for post-merger Takeda
Shire’s sales increased by 6% to $3.81bn
The deal will go ahead if the Japanese pharma company can secure an 85% stake in the biotech
Takeda has ex-US rights to the Crohn’s disease treatment from biotech TiGenix
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology